Literature DB >> 21415077

Molecular screening of ADAMTSL2 gene in 33 patients reveals the genetic heterogeneity of geleophysic dysplasia.

Slimane Allali1, Carine Le Goff, Isabelle Pressac-Diebold, Gwendoline Pfennig, Clémentine Mahaut, Nathalie Dagoneau, Yasemin Alanay, Angela F Brady, Yanick J Crow, Koen Devriendt, Valérie Drouin-Garraud, Elisabeth Flori, David Geneviève, Raoul C Hennekam, Jane Hurst, Deborah Krakow, Martine Le Merrer, Klaske D Lichtenbelt, Sally A Lynch, Stanislas Lyonnet, Kay MacDermot, Sahar Mansour, André Megarbané, Heloisa G Santos, Miranda Splitt, Andrea Superti-Furga, Sheila Unger, Denise Williams, Arnold Munnich, Valérie Cormier-Daire.   

Abstract

BACKGROUND: Geleophysic dysplasia (GD, OMIM 231050) is an autosomal recessive disorder characterised by short stature, small hands and feet, stiff joints, and thick skin. Patients often present with a progressive cardiac valvular disease which can lead to an early death. In a previous study including six GD families, we have mapped the disease gene on chromosome 9q34.2 and identified mutations in the A Disintegrin And Metalloproteinase with Thrombospondin repeats-like 2 gene (ADAMTSL2).
METHODS: Following this study, we have collected the samples of 30 additional GD families, including 33 patients and identified ADAMTSL2 mutations in 14/33 patients, comprising 13 novel mutations. The absence of mutation in 19 patients prompted us to compare the two groups of GD patients, namely group 1, patients with ADAMTSL2 mutations (n=20, also including the 6 patients from our previous study), and group 2, patients without ADAMTSL2 mutations (n=19).
RESULTS: The main discriminating features were facial dysmorphism and tip-toe walking, which were almost constantly observed in group 1. No differences were found concerning heart involvement, skin thickness, recurrent respiratory and ear infections, bronchopulmonary insufficiency, laryngo-tracheal stenosis, deafness, and radiographic features.
CONCLUSIONS: It is concluded that GD is a genetically heterogeneous condition. Ongoing studies will hopefully lead to the identification of another disease gene.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21415077      PMCID: PMC4413937          DOI: 10.1136/jmg.2010.087544

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  10 in total

1.  ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation.

Authors:  Carine Le Goff; Fanny Morice-Picard; Nathalie Dagoneau; Lauren W Wang; Claire Perrot; Yanick J Crow; Florence Bauer; Elisabeth Flori; Catherine Prost-Squarcioni; Deborah Krakow; Gaoxiang Ge; Daniel S Greenspan; Damien Bonnet; Martine Le Merrer; Arnold Munnich; Suneel S Apte; Valérie Cormier-Daire
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

2.  Acromicric dysplasia and geleophysic dysplasia: similarities and differences.

Authors:  R C Hennekam; Y van Bever; J W Oorthuys
Journal:  Eur J Pediatr       Date:  1996-04       Impact factor: 3.183

3.  Geleophysic dwarfism--a "focal" mucopolysaccharidosis?

Authors:  J W Spranger; E F Gilbert; G A Tuffli; F P Rossiter; J M Opitz
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

4.  Acromicric dysplasia: long term outcome and evidence of autosomal dominant inheritance.

Authors:  L Faivre; M Le Merrer; C Baumann; M Polak; P Chatelain; V Sulmont; J Cousin; M Bost; M P Cordier; E Zackai; K Russell; G Finidori; J C Pouliquen; A Munnich; P Maroteaux; V Cormier-Daire
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

5.  Nosology and classification of genetic skeletal disorders: 2006 revision.

Authors:  Andrea Superti-Furga; Sheila Unger
Journal:  Am J Med Genet A       Date:  2007-01-01       Impact factor: 2.802

Review 6.  Natural history of cardiac involvement in geleophysic dysplasia.

Authors:  A Scott; S Yeung; D F Dickinson; G Karbani; Y J Crow
Journal:  Am J Med Genet A       Date:  2005-01-30       Impact factor: 2.802

7.  ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome.

Authors:  Nathalie Dagoneau; Catherine Benoist-Lasselin; Céline Huber; Laurence Faivre; André Mégarbané; Abdulrahman Alswaid; Hélène Dollfus; Yves Alembik; Arnold Munnich; Laurence Legeai-Mallet; Valérie Cormier-Daire
Journal:  Am J Hum Genet       Date:  2004-09-13       Impact factor: 11.025

8.  In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome.

Authors:  L Faivre; R J Gorlin; M K Wirtz; M Godfrey; N Dagoneau; J R Samples; M Le Merrer; G Collod-Beroud; C Boileau; A Munnich; V Cormier-Daire
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

9.  Acromicric dysplasia.

Authors:  P Maroteaux; R Stanescu; V Stanescu; R Rappaport
Journal:  Am J Med Genet       Date:  1986-07

10.  Deregulation of EIF4E: a novel mechanism for autism.

Authors:  M Neves-Pereira; B Müller; D Massie; J H G Williams; P C M O'Brien; A Hughes; S-B Shen; David St Clair; Z Miedzybrodzka
Journal:  J Med Genet       Date:  2009-06-25       Impact factor: 6.318

  10 in total
  15 in total

1.  Three novel mutations of the FBN1 gene in Chinese children with acromelic dysplasia.

Authors:  Yu Wang; Huiwen Zhang; Jun Ye; Lianshu Han; Xuefan Gu
Journal:  J Hum Genet       Date:  2014-08-21       Impact factor: 3.172

2.  Limb- and tendon-specific Adamtsl2 deletion identifies a role for ADAMTSL2 in tendon growth in a mouse model for geleophysic dysplasia.

Authors:  Dirk Hubmacher; Nandaraj Taye; Zerina Balic; Stetson Thacker; Sheila M Adams; David E Birk; Ronen Schweitzer; Suneel S Apte
Journal:  Matrix Biol       Date:  2019-02-07       Impact factor: 11.583

3.  Mutations in the TGFβ binding-protein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias.

Authors:  Carine Le Goff; Clémentine Mahaut; Lauren W Wang; Slimane Allali; Avinash Abhyankar; Sacha Jensen; Louise Zylberberg; Gwenaelle Collod-Beroud; Damien Bonnet; Yasemin Alanay; Angela F Brady; Marie-Pierre Cordier; Koen Devriendt; David Genevieve; Pelin Özlem Simsek Kiper; Hiroshi Kitoh; Deborah Krakow; Sally Ann Lynch; Martine Le Merrer; André Mégarbane; Geert Mortier; Sylvie Odent; Michel Polak; Marianne Rohrbach; David Sillence; Irene Stolte-Dijkstra; Andrea Superti-Furga; David L Rimoin; Vicken Topouchian; Sheila Unger; Bernhard Zabel; Christine Bole-Feysot; Patrick Nitschke; Penny Handford; Jean-Laurent Casanova; Catherine Boileau; Suneel S Apte; Arnold Munnich; Valérie Cormier-Daire
Journal:  Am J Hum Genet       Date:  2011-06-16       Impact factor: 11.025

4.  Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome.

Authors:  Carine Le Goff; Clémentine Mahaut; Avinash Abhyankar; Wilfried Le Goff; Valérie Serre; Alexandra Afenjar; Anne Destrée; Maja di Rocco; Delphine Héron; Sébastien Jacquemont; Sandrine Marlin; Marleen Simon; John Tolmie; Alain Verloes; Jean-Laurent Casanova; Arnold Munnich; Valérie Cormier-Daire
Journal:  Nat Genet       Date:  2011-12-11       Impact factor: 38.330

Review 5.  Genetic and functional linkage between ADAMTS superfamily proteins and fibrillin-1: a novel mechanism influencing microfibril assembly and function.

Authors:  Dirk Hubmacher; Suneel S Apte
Journal:  Cell Mol Life Sci       Date:  2011-08-20       Impact factor: 9.261

Review 6.  Chondrodysplasias and TGFβ signaling.

Authors:  Carine Le Goff; Valerie Cormier-Daire
Journal:  Bonekey Rep       Date:  2015-03-11

Review 7.  Cardiac complications of congenital disorders of glycosylation (CDG): a systematic review of the literature.

Authors:  D Marques-da-Silva; R Francisco; D Webster; V Dos Reis Ferreira; J Jaeken; T Pulinilkunnil
Journal:  J Inherit Metab Dis       Date:  2017-07-19       Impact factor: 4.982

8.  O-Fucosylation of ADAMTSL2 is required for secretion and is impacted by geleophysic dysplasia-causing mutations.

Authors:  Ao Zhang; Steven J Berardinelli; Christina Leonhard-Melief; Deepika Vasudevan; Ta-Wei Liu; Andrew Taibi; Sharee Giannone; Suneel S Apte; Bernadette C Holdener; Robert S Haltiwanger
Journal:  J Biol Chem       Date:  2020-09-10       Impact factor: 5.157

9.  Acromelic dysplasias: how rare musculoskeletal disorders reveal biological functions of extracellular matrix proteins.

Authors:  Sarah Stanley; Zerina Balic; Dirk Hubmacher
Journal:  Ann N Y Acad Sci       Date:  2020-09-02       Impact factor: 5.691

10.  Adamtsl2 deletion results in bronchial fibrillin microfibril accumulation and bronchial epithelial dysplasia--a novel mouse model providing insights into geleophysic dysplasia.

Authors:  Dirk Hubmacher; Lauren W Wang; Robert P Mecham; Dieter P Reinhardt; Suneel S Apte
Journal:  Dis Model Mech       Date:  2015-03-11       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.